Eisai
4523.T
#1972
Rank
โ‚น711.75 B
Marketcap
โ‚น2,525
Share price
1.10%
Change (1 day)
-24.78%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Earnings for Eisai (4523.T)

Earnings in 2024 (TTM): โ‚น36.20 Billion

According to Eisai's latest financial reports the company's current earnings are โ‚น5.06 Billion. In 2023 the company made an earning of โ‚น45.62 Billion, an increase over its 2022 earnings that were of -โ‚น1.99 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Eisai from 2009 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) โ‚น36.20 B-20.63%
2023 โ‚น45.62 B-2392.87%
2022 -โ‚น1.99 Billion-103.6%
2021 โ‚น55.28 B-39.52%
2020 โ‚น91.40 B7.3%
2019 โ‚น85.18 B17.23%
2018 โ‚น72.67 B86.06%
2017 โ‚น39.05 B-23.64%
2016 โ‚น51.15 B27.28%
2015 โ‚น40.18 B22.08%
2014 โ‚น32.91 B-46.11%
2013 โ‚น61.08 B-21.67%
2012 โ‚น77.98 B-20.72%
2011 โ‚น98.37 B-8.44%
2010 โ‚น107.44 B18.85%
2009 โ‚น90.40 B